Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling

Zhao,Xuezhi; Guo,Xiaohan; Shen,Junhua; Hua,Dingchao

doi:10.3892/mmr.2018.9420

Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling

Authors:
- Xuezhi Zhao
- Xiaohan Guo
- Junhua Shen
- Dingchao Hua
View Affiliations

Affiliations: Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, P.R. China
Published online on: August 22, 2018 https://doi.org/10.3892/mmr.2018.9420
Pages: 4030-4036

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Natural bioactive components are increasingly being applied in cancer research. Alpinetin is a type of natural flavonoid primarily derived from Alpinia katsumadai Hayata, which exhibits anti‑bacterial and anti‑inflammatory properties. Therefore, it may possess anticancer potential and be employed therapeutically for different diseases. The aim of the present study was to investigate the anticancer effects of alpinetin on the SKOV3 ovarian cancer cell line. The effect of alpinetin treatment on SKOV3 cell proliferation, apoptosis, spheroid and colony formation were measured using Cell Counting kit‑8, cell apoptosis, 3D spheroid and colony formation assays, respectively. Analysis of the cell cycle was performed using flow cytometry. Western blot analysis was used to determine the protein expression levels of B‑cell lymphoma (Bcl)‑2, Bcl‑2‑associated X protein, cleaved caspase‑3, cleaved poly (ADP‑ribose) polymerase (PARP), cyclin D1, cyclin‑dependent kinase (CDK) 4, CDK6, signal transducer and activator of transcription (STAT) 3, phosphorylated (p)‑STAT3, c‑myc, survivin, tissue inhibitor of metalloproteinase (TIMP)‑1, TIMP‑2, matrix metalloproteinase (MMP)‑2 and MMP‑9. In addition, a wound healing assay was used to determine cancer cell migration. The results revealed alpinetin suppressed cell viability and induced apoptosis of SKOV3 cells in a dose‑ and time‑dependent manner, and cells were arrested in the G1 phase. Alpinetin treatment upregulated protein expression levels of Bax, cleaved caspase‑3 and PARP, and downregulated protein expression levels of Bcl‑2, cyclin D1, CDK4 and CDK6. Alpinetin also inhibited cell migration, through increased protein expression levels of TIMP‑1 and TIMP‑2, and decreased protein expression levels of MMP‑2 and MMP‑9. Alpinetin also significantly suppressed colony and spheroid formation by SKOV3 cells. In addition, the STAT3 pathway was suppressed as demonstrated by downregulation of p‑STAT3 and reduced expression of downstream factors, including c‑myc and survivin. Overall, these results indicated that alpinetin may have anticancer effects on human ovarian cancer by inhibiting the STAT3 signaling pathway.

View Figures

View References

1	Chien J and Poole EM: Ovarian cancer prevention, screening, and early detection: Report from the 11th biennial ovarian cancer research symposium. Int J Gynecol Cancer. 27 9S Suppl 5:S20–S22. 2017. View Article : Google Scholar : PubMed/NCBI
2	Choi JY, Lee S, Yun SM, Suh DH, Kim K, No JH, Jeong EH and Kim YB: Active hexose correlated compound (AHCC) inhibits the proliferation of ovarian cancer cells by suppressing signal transducer and activator of transcription 3 (STAT3) activation. Nutr Cancer. 70:109–115. 2018. View Article : Google Scholar : PubMed/NCBI
3	Li C, Hong L, Liu C, Min J, Hu M and Guo W: Astragalus polysaccharides increase the sensitivity of SKOV3 cells to cisplatin. Arch Gynecol Obstet. 297:381–386. 2017. View Article : Google Scholar : PubMed/NCBI
4	Chen SH, Murphy DA, Lassoued W, Thurston G, Feldman MD and Lee WM: Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther. 7:1994–2003. 2008. View Article : Google Scholar : PubMed/NCBI
5	Cai L, Zhang G, Tong X, You Q, An Y, Wang Y, Guo L, Wang T, Zhu D and Zheng J: Growth inhibition of human ovarian cancer cells by blocking STAT3 activation with small interfering RNA. Eur J Obstet Gynecol Reprod Biol. 148:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
6	Kumar J, Fang H, McCulloch DR, Crowley T and Ward AC: Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes. Oncotarget. 8:93530–93540. 2017.PubMed/NCBI
7	Jia Z, Jia Y, Guo FJ, Chen J, Zhang XW and Cui MH: Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer. PLoS One. 12:e1836222017. View Article : Google Scholar
8	Hirano T, Ishihara K and Hibi M: Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 19:2548–2556. 2000. View Article : Google Scholar : PubMed/NCBI
9	Landen CN, Lin YG, Armaiz Pena GN, Das PD, Arevalo JM, Kamat AA, Han LY, Jennings NB, Spannuth WA, Thaker PH, et al: Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res. 67:10389–10396. 2007. View Article : Google Scholar : PubMed/NCBI
10	Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
11	Harada D, Takigawa N and Kiura K: The role of STAT3 in non-small cell lung cancer. Cancers (Basel). 6:708–722. 2014. View Article : Google Scholar : PubMed/NCBI
12	Wu L, Yang W, Zhang SN and Lu JB: Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium. Drug Des Devel Ther. 9:6119–6127. 2015.PubMed/NCBI
13	Wang Z, Lu W, Li Y and Tang B: Alpinetin promotes Bax translocation, induces apoptosis through the mitochondrial pathway and arrests human gastric cancer cells at the G2/M phase. Mol Med Rep. 7:915–920. 2013. View Article : Google Scholar : PubMed/NCBI
14	Tang B, Du J, Wang J, Tan G, Gao Z, Wang Z and Wang L: Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium. Oncol Rep. 27:1090–1096. 2012. View Article : Google Scholar : PubMed/NCBI
15	Wang J, Yan Z, Liu X, Che S, Wang C and Yao W: Alpinetin targets glioma stem cells by suppressing Notch pathway. Tumor Biol. 37:9243–9248. 2016. View Article : Google Scholar
16	Du J, Tang B, Wang J, Sui H, Jin X, Wang L and Wang Z: Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. Int J Mol Med. 29:607–612. 2012. View Article : Google Scholar : PubMed/NCBI
17	Ajmala Shireen P, Abdul Mujeeb VM and Muraleedharan K: Theoretical insights on flavanones as antioxidants and UV filters: A TDDFT and NLMO study. J Photochem Photobiol B. 170:286–294. 2017. View Article : Google Scholar : PubMed/NCBI
18	Huo M, Chen N, Chi G, Yuan X, Guan S, Li H, Zhong W, Guo W, Soromou LW, Gao R, et al: Traditional medicine alpinetin inhibits the inflammatory response in Raw 264.7 cells and mouse models. Int Immunopharmacol. 12:241–248. 2012. View Article : Google Scholar : PubMed/NCBI
19	Malami I, Abdul AB, Abdullah R, Kassim NK, Rosli R, Yeap SK, Waziri P, Etti IC and Bello MB: Correction: Crude extracts, flavokawain B and alpinetin compounds from the rhizome of Alpinia mutica induce cell death via UCK2 enzyme inhibition and in turn reduce 18S rRNA biosynthesis in HT-29 cells. PLoS One. 12:e1702332017. View Article : Google Scholar
20	Sun X, Lin L, Chen Y, Liu T, Liu R, Wang Z, Mou K, Xu J, Li B and Song H: Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway. Mol Med Rep. 13:3161–3168. 2016. View Article : Google Scholar : PubMed/NCBI
21	Park MK, Jo SH, Lee HJ, Kang JH, Kim YR, Kim HJ, Lee EJ, Koh JY, Ahn KO, Jung KC, et al: Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells. Life Sci. 92:154–160. 2013. View Article : Google Scholar : PubMed/NCBI
22	Tang JM, Min J, Li BS, Hong SS, Liu C, Hu M, Li Y, Yang J and Hong L: Therapeutic effects of punicalagin against ovarian carcinoma cells in association with β-catenin signaling inhibition. Int J Gynecol Cancer. 26:1557–1563. 2016. View Article : Google Scholar : PubMed/NCBI